Τίτλος:
Adaptive radiation therapy: When, how and what are the benefits that literature provides? [Radiothérapie adaptative : quand, comment et quels sont les avantages que procure la littérature ?]
Περίληψη:
Purpose: To identify from the current literature when is the right time to replan and to assign thresholds for the optimum process of replanning. Nowadays, adaptive radiotherapy (ART) for head and neck cancer plays an exceptional role consisting of an evaluation procedure of the prominent anatomical and dosimetric variations. By performing complex radiotherapy methods, the credibility of the therapeutic result is crucial. Image guided radiotherapy (IGRT) was developed to ensure locoregional control and thus changes that might occur during radiotherapy be dealt with. Materials and methods: An electronic research of articles published in PubMed/MEDLINE and Science Direct databases from January 2004 to October 2020 was performed. Among a total of 127 studies assessed for eligibility, 85 articles were ultimately retained for the review. Results: The most noticeable changes have been reported in the middle fraction of the treatment. Therefore, the suggested optimal time to replan is between the third and the fourth week. Anatomical deviations > 1 cm in the external contour, average weight loss > 10%, violation in the dose coverage of the targets > 5%, and violation in the dose of the peripherals were some of the thresholds that are currently used, and which lead to replanning. Conclusion: ART may decrease toxicity and improve local-control. Whether it is beneficial or not, depends ultimately on each patient. However, more investigation of the changes should be performed in future prospective studies to obtain more accurate results. © 2021 Société française de radiothérapie oncologique (SFRO)
Συγγραφείς:
Avgousti, R.
Antypas, C.
Armpilia, C.
Simopoulou, F.
Liakouli, Z.
Karaiskos, P.
Kouloulias, V.
Kyrodimos, E.
Moulopoulos, L.A.
Zygogianni, A.
Περιοδικό:
Cancer: Radiotherapie
Εκδότης:
Elsevier Masson s.r.l.
DOI:
10.1016/j.canrad.2021.08.023
